Monthly Archives: November 2021

9 Nov 2021 Stéphane Barritault

News

Nov 9, 2021 – Clinical

OTR3 starts a post market clinical follow up on Cacipliq 20®.

A synthetic glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan species during myogenesis
Effect of a Matrix Therapy Agent on Corneal Epithelial Healing After Standard Collagen Cross-linking in Patients With Keratoconus: A Randomized Clinical Trial
A substituted dextran enhances muscle fiber survival and regeneration in ischemic and denervated rat EDL muscle
A new approach to treat tissue destruction in periodontitis with chemically modified dextran polymers
A heparan sulfate-based matrix therapy reduces brain damage and enhances functional recovery following stroke